TreeWAS – Variant ID: rs28890483

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H02.8 Other specified disorders of eyelid	0.000	0.986	0.014
I34.0 Mitral (valve) insufficiency	0.000	0.987	0.013
I34 Nonrheumatic mitral valve disorders	0.000	0.990	0.010
I34.1 Mitral (valve) prolapse	0.000	0.990	0.010
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.991	0.009
N92.3 Ovulation bleeding	0.000	0.992	0.008
T39.0 Salicylates	0.000	0.992	0.008
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.993	0.007
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.000	0.993	0.007
I34.8 Other nonrheumatic mitral valve disorders	0.000	0.993	0.007
I34.2 Nonrheumatic mitral (valve) stenosis	0.000	0.993	0.007
N92.0 Excessive and frequent menstruation with regular cycle	0.000	0.993	0.007
N92 Excessive, frequent and irregular menstruation	0.000	0.993	0.007
N92.1 Excessive and frequent menstruation with irregular cycle	0.000	0.994	0.006
G81.9 Hemiplegia, unspecified	0.006	0.994	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.994	0.006
H02 Other disorders of eyelid	0.000	0.994	0.006
N92.5 Other specified irregular menstruation	0.000	0.994	0.006
O36.8 Maternal care for other specified foetal problems	0.000	0.994	0.006
Z03.3 Observation for suspected nervous system disorder	0.000	0.994	0.006
C56 Malignant neoplasm of ovary	0.006	0.994	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.994	0.005
T39.4 Antirheumatics, not elsewhere classified	0.000	0.994	0.005
T39.2 Pyrazolone derivatives	0.000	0.994	0.005
H02.3 Blepharochalasis	0.000	0.995	0.005
H02.0 Entropion and trichiasis of eyelid	0.000	0.995	0.005
N92.2 Excessive menstruation at puberty	0.000	0.995	0.005
H02.4 Ptosis of eyelid	0.000	0.995	0.005
H02.2 Lagophthalmos	0.000	0.995	0.005
N92.4 Excessive bleeding in the premenopausal period	0.000	0.995	0.005
F10.0 Acute intoxication	0.000	0.995	0.005
H02.7 Other degenerative disorders of eyelid and periocular area	0.000	0.995	0.004
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
H02.5 Other disorders affecting eyelid function	0.000	0.996	0.004
Z86.1 Personal history of infectious and parasitic diseases	0.000	0.996	0.004
T42.4 Benzodiazepines	0.000	0.996	0.004
Y86 Sequelae of other accidents	0.000	0.996	0.004
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.996	0.004
N92.6 Irregular menstruation, unspecified	0.000	0.996	0.004
C71.2 Temporal lobe	0.004	0.996	0.000
C71.0 Cerebrum, except lobes and ventricles	0.004	0.996	0.000
I20.8 Other forms of angina pectoris	0.000	0.996	0.004
C71 Malignant neoplasm of brain	0.004	0.996	0.000
H02.1 Ectropion of eyelid	0.000	0.996	0.004
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.996	0.004
H02.6 Xanthelasma of eyelid	0.000	0.996	0.004
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.996	0.004
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
C71.3 Parietal lobe	0.004	0.996	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
I20.0 Unstable angina	0.000	0.996	0.004
C71.9 Brain, unspecified	0.003	0.996	0.000
I20.1 Angina pectoris with documented spasm	0.000	0.997	0.003
O70.1 Second degree perineal laceration during delivery	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.997	0.003
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
I20 Angina pectoris	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
N39.4 Other specified urinary incontinence	0.000	0.997	0.003
T42.1 Iminostilbenes	0.000	0.997	0.003
T45.0 Antiallergic and antiemetic drugs	0.000	0.997	0.003
G81 Hemiplegia	0.003	0.997	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
C71.7 Brain stem	0.003	0.997	0.000
C71.6 Cerebellum	0.003	0.997	0.000
C71.5 Cerebral ventricle	0.003	0.997	0.000
C71.4 Occipital lobe	0.003	0.997	0.000
O72.1 Other immediate postpartum haemorrhage	0.000	0.997	0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.003
T42.3 Barbiturates	0.000	0.997	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.003
T42.0 Hydantoin derivatives	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
R16.1 Splenomegaly, not elsewhere classified	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
C71.8 Overlapping lesion of brain	0.003	0.997	0.000
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.003
C53.9 Cervix uteri, unspecified	0.003	0.997	0.000
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.997	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.002
T45.4 Iron and its compounds	0.000	0.997	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.002
O36 Maternal care for other known or suspected foetal problems	0.000	0.997	0.003
C53 Malignant neoplasm of cervix uteri	0.003	0.997	0.000
C16.0 Cardia	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.002
T44.0 Anticholinesterase agents	0.000	0.997	0.002
O20.9 Haemorrhage in early pregnancy, unspecified	0.000	0.997	0.003
T39.1 4-Aminophenol derivatives	0.000	0.997	0.002
T45.5 Anticoagulants	0.000	0.997	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.002
C51-C58 Malignant neoplasms of female genital organs	0.003	0.997	0.000
C71.1 Frontal lobe	0.002	0.997	0.000
G81.1 Spastic hemiplegia	0.002	0.997	0.000
G81.0 Flaccid hemiplegia	0.002	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.002
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.000	0.998	0.002
T50.8 Diagnostic agents	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
R61.9 Hyperhidrosis, unspecified	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
R16.0 Hepatomegaly, not elsewhere classified	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
R16 Hepatomegaly and splenomegaly, not elsewhere classified	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
O36.6 Maternal care for excessive foetal growth	0.000	0.998	0.002
I12.0 Hypertensive renal disease with renal failure	0.002	0.998	0.000
O36.5 Maternal care for poor foetal growth	0.000	0.998	0.002
I61.9 Intracerebral haemorrhage, unspecified	0.002	0.998	0.000
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified	0.000	0.998	0.002
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.000	0.998	0.002
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.000	0.998	0.002
O36.4 Maternal care for intra-uterine death	0.000	0.998	0.002
O36.2 Maternal care for hydrops foetalis	0.000	0.998	0.002
O36.1 Maternal care for other isoimmunisation	0.000	0.998	0.002
Z29.1 Prophylactic immunotherapy	0.002	0.998	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
C53.8 Overlapping lesion of cervix uteri	0.002	0.998	0.000
C53.1 Exocervix	0.002	0.998	0.000
C53.0 Endocervix	0.002	0.998	0.000
O36.3 Maternal care for signs of foetal hypoxia	0.000	0.998	0.002
C52 Malignant neoplasm of vagina	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
C57 Malignant neoplasm of other and unspecified female genital organs	0.002	0.998	0.000
C58 Malignant neoplasm of placenta	0.002	0.998	0.000
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.000	0.998	0.002
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
E28.2 Polycystic ovarian syndrome	0.000	0.998	0.002
B34.9 Viral infection, unspecified	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
O36.0 Maternal care for rhesus isoimmunisation	0.000	0.998	0.002
C44.6 Skin of upper limb, including shoulder	0.000	0.998	0.002
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.000	0.998	0.002
I69.1 Sequelae of intracerebral haemorrhage	0.002	0.998	0.000
E78.5 Hyperlipidaemia, unspecified	0.000	0.998	0.002
J45.0 Predominantly allergic asthma	0.002	0.998	0.000
H05.2 Exophthalmic conditions	0.000	0.998	0.002
O36.9 Maternal care for foetal problem, unspecified	0.000	0.998	0.002
O72.0 Third-stage haemorrhage	0.000	0.998	0.002
C55 Malignant neoplasm of uterus, part unspecified	0.002	0.998	0.000
I69.3 Sequelae of cerebral infarction	0.002	0.998	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.002	0.998	0.000
I67.1 Cerebral aneurysm, nonruptured	0.002	0.998	0.000
K60.3 Anal fistula	0.000	0.998	0.002
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
C51 Malignant neoplasm of vulva	0.002	0.998	0.000
I69 Sequelae of cerebrovascular disease	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
O72 Postpartum haemorrhage	0.000	0.998	0.002
C57.9 Female genital organ, unspecified	0.002	0.998	0.000
C57.8 Overlapping lesion of female genital organs	0.002	0.998	0.000
C57.7 Other specified female genital organs	0.002	0.998	0.000
C57.4 Uterine adnexa, unspecified	0.002	0.998	0.000
C57.3 Parametrium	0.002	0.998	0.000
C57.2 Round ligament	0.002	0.998	0.000
C57.1 Broad ligament	0.002	0.998	0.000
C57.0 Fallopian tube	0.002	0.998	0.000
O04.9 Complete or unspecified, without complication	0.002	0.998	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.000	0.998	0.002
T78.2 Anaphylactic shock, unspecified	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.001
T40.8 Lysergide [LSD]	0.000	0.998	0.001
T40.7 Cannabis (derivatives)	0.000	0.998	0.001
T40.6 Other and unspecified narcotics	0.000	0.998	0.001
T40.5 Cocaine	0.000	0.998	0.001
T40.3 Methadone	0.000	0.998	0.001
T40.1 Heroin	0.000	0.998	0.001
T40.0 Opium	0.000	0.998	0.001
S22.40 Multiple fractures of ribs (closed)	0.000	0.998	0.002
E89.0 Postprocedural hypothyroidism	0.002	0.998	0.000
O94-O99 Other obstetric conditions, not elsewhere classified	0.000	0.998	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
C69 Malignant neoplasm of eye and adnexa	0.002	0.998	0.000
C54 Malignant neoplasm of corpus uteri	0.002	0.998	0.000
C69.3 Choroid	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.000	0.998	0.001
T78.3 Angioneurotic oedema	0.000	0.998	0.002
C54.9 Corpus uteri, unspecified	0.002	0.998	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.002	0.998	0.000
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.002	0.998	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.001	0.998	0.000
C70 Malignant neoplasm of meninges	0.001	0.998	0.000
C51.8 Overlapping lesion of vulva	0.001	0.998	0.000
C51.2 Clitoris	0.001	0.998	0.000
C51.1 Labium minus	0.001	0.998	0.000
C51.0 Labium majus	0.001	0.998	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.001	0.998	0.000
H57.1 Ocular pain	0.002	0.998	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.001	0.998	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.000	0.998	0.002
O72.3 Postpartum coagulation defects	0.000	0.998	0.001
H04.5 Stenosis and insufficiency of lachrymal passages	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
H05 Disorders of orbit	0.000	0.998	0.001
N99.4 Postprocedural pelvic peritoneal adhesions	0.000	0.998	0.001
O70.9 Perineal laceration during delivery, unspecified	0.000	0.998	0.001
O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.001
O97 Death from sequelae of direct obstetric causes	0.000	0.998	0.001
O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery	0.000	0.998	0.001
O95 Obstetric death of unspecified cause	0.000	0.998	0.001
O94 Sequelae of complication of pregnancy, childbirth and the puerperium	0.000	0.998	0.001
C69.8 Overlapping lesion of eye and adnexa	0.001	0.998	0.000
C69.6 Orbit	0.001	0.998	0.000
C69.5 Lachrymal gland and duct	0.001	0.998	0.000
C69.4 Ciliary body	0.001	0.998	0.000
C69.2 Retina	0.001	0.998	0.000
C69.1 Cornea	0.001	0.998	0.000
C69.0 Conjunctiva	0.001	0.998	0.000
O70 Perineal laceration during delivery	0.000	0.998	0.002
Z29 Need for other prophylactic measures	0.002	0.998	0.000
N84.0 Polyp of corpus uteri	0.000	0.998	0.002
Z29.0 Isolation	0.001	0.998	0.000
Z29.8 Other specified prophylactic measures	0.001	0.999	0.000
C54.8 Overlapping lesion of corpus uteri	0.001	0.999	0.000
C54.3 Fundus uteri	0.001	0.999	0.000
C54.2 Myometrium	0.001	0.999	0.000
C54.0 Isthmus uteri	0.001	0.999	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.001	0.999	0.000
O70.2 Third degree perineal laceration during delivery	0.000	0.999	0.001
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.000	0.999	0.001
S72.30 Fracture of shaft of femur (closed)	0.000	0.999	0.001
H02.9 Disorder of eyelid, unspecified	0.000	0.999	0.001
I20.9 Angina pectoris, unspecified	0.000	0.999	0.001
I61 Intracerebral haemorrhage	0.001	0.999	0.000
T78 Adverse effects, not elsewhere classified	0.000	0.999	0.001
C69.9 Eye, unspecified	0.001	0.999	0.000
C70.9 Meninges, unspecified	0.001	0.999	0.000
C70.1 Spinal meninges	0.001	0.999	0.000
C70.0 Cerebral meninges	0.001	0.999	0.000
C72.9 Central nervous system, unspecified	0.001	0.999	0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.001	0.999	0.000
C72.5 Other and unspecified cranial nerves	0.001	0.999	0.000
C72.4 Acoustic nerve	0.001	0.999	0.000
C72.3 Optic nerve	0.001	0.999	0.000
C72.2 Olfactory nerve	0.001	0.999	0.000
C72.1 Cauda equina	0.001	0.999	0.000
C72.0 Spinal cord	0.001	0.999	0.000
C16 Malignant neoplasm of stomach	0.001	0.999	0.000
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.000	0.999	0.001
C16.2 Body of stomach	0.001	0.999	0.000
Y42.5 Other oestrogens and progestogens	0.000	0.999	0.001
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.000	0.999	0.001
C16.3 Pyloric antrum	0.001	0.999	0.000
H06.2 Dysthyroid exophthalmos	0.000	0.999	0.001
Y89 Sequelae of other external causes	0.000	0.999	0.001
E21.0 Primary hyperparathyroidism	0.000	0.999	0.001
H05.9 Disorder of orbit, unspecified	0.000	0.999	0.001
H05.8 Other disorders of orbit	0.000	0.999	0.001
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.000	0.999	0.001
H05.4 Enophthalmos	0.000	0.999	0.001
H05.3 Deformity of orbit	0.000	0.999	0.001
H05.1 Chronic inflammatory disorders of orbit	0.000	0.999	0.001
I61.8 Other intracerebral haemorrhage	0.001	0.999	0.000
A63.0 Anogenital (venereal) warts	0.000	0.999	0.001
C51.9 Vulva, unspecified	0.001	0.999	0.000
I67.8 Other specified cerebrovascular diseases	0.001	0.999	0.000
I86.4 Gastric varices	0.000	0.999	0.001
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.999	0.001
O96.9 Death from unspecified obstetric cause	0.000	0.999	0.001
O96.1 Death from indirect obstetric cause	0.000	0.999	0.001
O96.0 Death from direct obstetric cause	0.000	0.999	0.001
O97.9 Death from sequelae of obstetric cause, unspecified	0.000	0.999	0.001
O97.1 Death from sequelae of indirect obstetric cause	0.000	0.999	0.001
O97.0 Death from sequelae of direct obstetric cause	0.000	0.999	0.001
O98.9 Unspecified maternal infectious or parasitic disease complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
O98.8 Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
O98.7 Human immunodeficiency [HIV] disease complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
O98.6 Protozoal diseases complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
O98.5 Other viral diseases complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
O98.4 Viral hepatitis complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
O98.3 Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
O98.2 Gonorrhoea complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
O98.1 Syphilis complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
O98.0 Tuberculosis complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
Z29.9 Prophylactic measure, unspecified	0.001	0.999	0.000
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.000	0.999	0.001
C16.5 Lesser curvature of stomach, unspecified	0.001	0.999	0.000
O70.3 Fourth degree perineal laceration during delivery	0.000	0.999	0.001
Y87.1 Sequelae of assault	0.000	0.999	0.001
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.000	0.999	0.001
T78.0 Anaphylactic shock due to adverse food reaction	0.000	0.999	0.001
Y85.9 Sequelae of other and unspecified transport accidents	0.000	0.999	0.001
Y85 Sequelae of transport accidents	0.000	0.999	0.001
N99.8 Other postprocedural disorders of genito-urinary system	0.000	0.999	0.001
Y87.2 Sequelae of events of undetermined intent	0.000	0.999	0.001
Y87.0 Sequelae of intentional self-harm	0.000	0.999	0.001
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)	0.000	0.999	0.001
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.999	0.001
C16.8 Overlapping lesion of stomach	0.001	0.999	0.000
C16.6 Greater curvature of stomach, unspecified	0.001	0.999	0.000
C16.4 Pylorus	0.001	0.999	0.000
C16.1 Fundus of stomach	0.001	0.999	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.001	0.999	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.001	0.999	0.000
I84.3 External thrombosed haemorrhoids	0.000	0.999	0.001
N76.4 Abscess of vulva	0.000	0.999	0.001
T78.9 Adverse effect, unspecified	0.000	0.999	0.001
T78.8 Other adverse effects, not elsewhere classified	0.000	0.999	0.001
H06.3 Other disorders of orbit in diseases classified elsewhere	0.000	0.999	0.001
H06.1 Parasitic infestation of orbit in diseases classified elsewhere	0.000	0.999	0.001
H06.0 Disorders of lachrymal system in diseases classified elsewhere	0.000	0.999	0.001
I67 Other cerebrovascular diseases	0.001	0.999	0.000
Y89.1 Sequelae of war operations	0.000	0.999	0.001
Y89.0 Sequelae of legal intervention	0.000	0.999	0.001
T78.4 Allergy, unspecified	0.000	0.999	0.001
Y89.9 Sequelae of unspecified external cause	0.000	0.999	0.001
B34.8 Other viral infections of unspecified site	0.000	0.999	0.001
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.000	0.999	0.001
S22.4 Multiple fractures of ribs	0.000	0.999	0.001
T78.1 Other adverse food reactions, not elsewhere classified	0.000	0.999	0.001
S22.30 Fracture of rib (closed)	0.000	0.999	0.001
G56.0 Carpal tunnel syndrome	0.000	0.999	0.001
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.001	0.999	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.001	0.999	0.000
B34 Viral infection of unspecified site	0.000	0.999	0.001
E28 Ovarian dysfunction	0.000	0.999	0.001
I61.4 Intracerebral haemorrhage in cerebellum	0.001	0.999	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.001	0.999	0.000
O72.2 Delayed and secondary postpartum haemorrhage	0.000	0.999	0.001
R25.2 Cramp and spasm	0.000	0.999	0.001
Z29.2 Other prophylactic chemotherapy	0.001	0.999	0.000
H03 Disorders of eyelid in diseases classified elsewhere	0.000	0.999	0.001
M77.12 Lateral epicondylitis (Upper arm)	0.001	0.999	0.000
I67.7 Cerebral arteritis, not elsewhere classified	0.001	0.999	0.000
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.001	0.999	0.000
I67.5 Moyamoya disease	0.001	0.999	0.000
I67.4 Hypertensive encephalopathy	0.001	0.999	0.000
I67.3 Progressive vascular leukoencephalopathy	0.001	0.999	0.000
I67.0 Dissection of cerebral arteries, nonruptured	0.001	0.999	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.999	0.001
Z50.5 Speech therapy	0.001	0.999	0.000
Y88 Sequelae of surgical and medical care as external cause	0.000	0.999	0.001
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.000	0.999	0.001
S22.41 Multiple fractures of ribs (open)	0.000	0.999	0.001
B34.3 Parvovirus infection, unspecified	0.000	0.999	0.001
B34.2 Coronavirus infection, unspecified	0.000	0.999	0.001
B34.1 Enterovirus infection, unspecified	0.000	0.999	0.001
B34.0 Adenovirus infection, unspecified	0.000	0.999	0.001
H05.0 Acute inflammation of orbit	0.000	0.999	0.001
N94.9 Unspecified condition associated with female genital organs and menstrual cycle	0.000	0.999	0.001
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.000	0.999	0.001
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.000	0.999	0.001
E23.0 Hypopituitarism	0.000	0.999	0.001
E28.9 Ovarian dysfunction, unspecified	0.000	0.999	0.001
E28.8 Other ovarian dysfunction	0.000	0.999	0.001
E28.1 Androgen excess	0.000	0.999	0.001
E28.0 Oestrogen excess	0.000	0.999	0.001
L28.0 Lichen simplex chronicus	0.001	0.999	0.000
H04 Disorders of lachrymal system	0.000	0.999	0.001
H03.8 Involvement of eyelid in other diseases classified elsewhere	0.000	0.999	0.001
H03.0 Parasitic infestation of eyelid in diseases classified elsewhere	0.000	0.999	0.001
L05.9 Pilonidal cyst without abscess	0.000	0.999	0.001
Y88.2 Sequelae of adverse incidents associated with medical devices in diagnostic and therapeutic use	0.000	0.999	0.001
Y88.1 Sequelae of misadventures to patients during surgical and medical procedures	0.000	0.999	0.001
Y88.0 Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use	0.000	0.999	0.001
H04.3 Acute and unspecified inflammation of lachrymal passages	0.000	0.999	0.001
H57.0 Anomalies of pupillary function	0.001	0.999	0.000
M84.1 Nonunion of fracture [pseudarthrosis]	0.000	0.999	0.001
H04.9 Disorder of lachrymal system, unspecified	0.000	0.999	0.001
H04.8 Other disorders of lachrymal system	0.000	0.999	0.001
H04.6 Other changes in lachrymal passages	0.000	0.999	0.001
H04.0 Dacryoadenitis	0.000	0.999	0.001
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.000	0.999	0.001
N99.1 Postprocedural urethral stricture	0.000	0.999	0.001
M21.16 Varus deformity, not elsewhere classified (Lower leg)	0.001	0.999	0.000
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)	0.000	0.999	0.001
M84.18 Nonunion of fracture [pseudarthrosis] (Other)	0.000	0.999	0.001
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)	0.000	0.999	0.001
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)	0.000	0.999	0.001
B34.4 Papovirus infection, unspecified	0.000	0.999	0.001
E28.3 Primary ovarian failure	0.001	0.999	0.001
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.999	0.001
I65.0 Occlusion and stenosis of vertebral artery	0.001	0.999	0.000
S02.60 Fracture of mandible (closed)	0.001	0.999	0.000
E22.1 Hyperprolactinaemia	0.000	0.999	0.001
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.999	0.001
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.001	0.999	0.000
C16.9 Stomach, unspecified	0.001	0.999	0.000
D59.1 Other autoimmune haemolytic anaemias	0.001	0.999	0.000
E22.0 Acromegaly and pituitary gigantism	0.000	0.999	0.001
H03.1 Involvement of eyelid in other infectious diseases classified elsewhere	0.000	0.999	0.001
J64 Unspecified pneumoconiosis	0.001	0.999	0.000
L84 Corns and callosities	0.000	0.999	0.001
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.000	0.999	0.001
T17.2 Foreign body in pharynx	0.000	0.999	0.001
T40.2 Other opioids	0.001	0.999	0.000
Z48.8 Other specified surgical follow-up care	0.001	0.999	0.000
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.001	0.999	0.000
D68.8 Other specified coagulation defects	0.000	0.999	0.001
I65.2 Occlusion and stenosis of carotid artery	0.001	0.999	0.000
I67.2 Cerebral atherosclerosis	0.001	0.999	0.000
S22.31 Fracture of rib (open)	0.000	0.999	0.001
D61.9 Aplastic anaemia, unspecified	0.000	0.999	0.001
I27.2 Other secondary pulmonary hypertension	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations